| scholarly article | Q13442814 |
| P50 | author | Santa Rasa | Q84884815 |
| Modra Murovska | Q85228240 | ||
| P2093 | author name string | Svetlana Chapenko | |
| Angelika Krumina | |||
| Alina Sultanova | |||
| Inara Logina | |||
| Ludmila Viksna | |||
| Maksims Chistjakovs | |||
| P2860 | cites work | Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus | Q24563317 |
| Myalgic encephalomyelitis: International Consensus Criteria | Q24611510 | ||
| Identification of marker genes for differential diagnosis of chronic fatigue syndrome | Q24648930 | ||
| Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients | Q28140056 | ||
| Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study | Q28141932 | ||
| Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome | Q28217481 | ||
| The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group | Q28241826 | ||
| Is human herpesvirus-6 a trigger for chronic fatigue syndrome? | Q28286760 | ||
| Prevalence of IgM Antibodies to Human Herpesvirus 6 Early Antigen (p41/38) in Patients with Chronic Fatigue Syndrome | Q28292162 | ||
| Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction | Q28306691 | ||
| Bayesian biomarker identification based on marker-expression proteomics data. | Q31165321 | ||
| Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome | Q57279208 | ||
| Postinfective Fatigue Syndrome Is Not Associated with Altered Cytokine Production | Q59200563 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome | Q74617924 | ||
| Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR | Q78643374 | ||
| Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome | Q33271849 | ||
| Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. | Q33341581 | ||
| Evidence for a heritable predisposition to Chronic Fatigue Syndrome | Q33914379 | ||
| Parvovirus-like particles in human sera | Q34214388 | ||
| IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome | Q34316877 | ||
| Chronic Fatigue Syndrome and Herpesviruses: the Fading Evidence. | Q34521299 | ||
| Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach | Q34687852 | ||
| Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. | Q34714439 | ||
| Persistence of human parvovirus B19 in human tissues | Q34737815 | ||
| Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia | Q34750380 | ||
| Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy | Q34882969 | ||
| B19 virus infection in renal transplant recipients | Q35085350 | ||
| Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome | Q35208428 | ||
| HHV-6 and the immune system: mechanisms of immunomodulation and viral escape | Q36727461 | ||
| Plasma cytokines in women with chronic fatigue syndrome | Q37426905 | ||
| Chronic fatigue syndrome, the immune system and viral infection | Q37901163 | ||
| Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates | Q42806799 | ||
| Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. | Q44380438 | ||
| Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. | Q44420596 | ||
| CD46 is a cellular receptor for human herpesvirus 6. | Q44613357 | ||
| Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in Latvia | Q45734360 | ||
| Erythrocyte P antigen: cellular receptor for B19 parvovirus | Q45873217 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 205085 | |
| P577 | publication date | 2012-08-13 | |
| P1433 | published in | Advances in virology | Q26842424 |
| P1476 | title | Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome | |
| P478 | volume | 2012 |
| Q37363077 | A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers |
| Q93047773 | Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients |
| Q33737919 | Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers |
| Q57058470 | Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) |
| Q90403930 | Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy |
| Q90026907 | Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome |
| Q37484088 | Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome |
| Q41002451 | Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy |
| Q34306768 | EBV, HCMV, HHV6, and HHV7 screening in bone marrow samples from children with acute lymphoblastic leukemia. |
| Q35154802 | Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial |
| Q50689763 | Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. |
| Q33649866 | Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters. |
| Q40430043 | Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. |
| Q31152067 | Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease |
| Q50333926 | Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model |
| Q60046972 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity |
| Q40288220 | Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology |
| Q91810416 | Presence of B19V in Patients with Thyroid Gland Disorders |
| Q34537814 | Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals |
| Q39435551 | The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE. |
| Q38529622 | The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability. |
| Q30575382 | The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups. |
Search more.